UW Health and the University of Wisconsin School of Medicine and Public Health (SMPH) are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2.

“UW Health and SMPH are proud to be at the forefront of working toward identifying safe, effective solutions to this global pandemic,” says Betsy Nugent, Chief Clinical Research Officer at UW Health and SMPH. “Our entire team has been working diligently for months to bring this important cl...